A phase II study of CCNU with benznidazole for metastatic malignant melanoma
Authors:
- Norman M. BleehenNBNorman M. Bleehen
- J. Trevor RobertsJRJ. Trevor Roberts
- Hugh F.V. NewmanHNHugh F.V. Newman
- 31 August 1986
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 12 (8) , 1401-1403
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Benznidazole with CCNU: A clinical phase i toxicity studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1985
- Preclinical pharmacokinetics of benznidazoleBritish Journal of Cancer, 1984
- A phase I study of the hypoxic cell radiosensitizer Ro-03-8799International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1984
- Modification of chemotherapy by nitroimidazolesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1984
- Chemosensitization by lipophilic nitroimidazolesBritish Journal of Cancer, 1983
- Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNUBritish Journal of Cancer, 1982
- The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazolesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982
- Hypoxia-mediated druGS FOR RADIATION AND CHEMOTHERAPYCancer, 1981
- Integration of chemotherapy into combined modality therapy of solid tumorsCancer Treatment Reviews, 1974